The Magazine for Sleep Professionals
Saturday, August 29, 2026
EnsoData has announced a collaboration with Takeda to jointly develop and validate AI-based polysomnography (PSG) algorithms to support more accurate and scalable diagnosis of narcolepsy type 1 (NT1). Upon successful validation and regulatory clearance, EnsoData will pursue the clinical availability and release of AI algorithms to enable future access, use, […]
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and […]
A significant number of people in America are walking around with undiagnosed sleep disorders. Recent studies indicate 14.5 percent of adults in the U.S. have difficulty falling asleep, and 17.8 percent had difficulty staying asleep.1 While these alarming statistics highlight the urgent need for sleep disorder testing and treatment nationwide, […]
EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in the US alone, an estimated 54 million patients suffering from […]
Nox Medical, a global leader in sleep diagnostic solutions, is proud to unveil the expanded capabilities of Nox Connect™, a secure, cloud-based platform that now features Artificial Intelligence, web-based scoring and interpretation, and a fully integrated Home Sleep Testing Service. The new platform features will be showcased at the SLEEP […]
Revolutionizing sleep health with an all-in-one, AI-driven diagnostics platform. Delivering real-time physiological data monitoring and sleep analysis that matches the accuracy and quality of in-lab studies, with the comfort and convenience of at-home testing. Dormotech, a leader in advancing sleep diagnostics through innovative, clinically validated solutions, is proud to launch […]
EnsoData, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO). Cockrill will oversee strategy and execution of sales and marketing functions and continue accelerating EnsoSleep PPG™, EnsoSleep™, RPM, and EnsoTherapy™ adoption across North America. Cockrill comes from Bardy Diagnostics (BDx), where he […]
EnsoData, a leader in healthcare AI technology, is partnering with Advanced Brain Monitoring (ABM) to add position data captured by ABM’s Night Shift sleep positioner into the FDA-cleared EnsoSleep PPG home sleep test (HST). Adding positional data to EnsoSleep PPG offers providers accurate supine AHI severity insights, leading to better […]
EnsoData, an innovator in AI healthtech solutions, is proud to introduce a new RPM (remote physiological monitoring) offering to the EnsoSleep PPG ecosystem of AI tools. EnsoData’s RPM solution allows clinicians to seamlessly monitor patients over time and proactively intervene when patients need support with their therapy the most. RPM […]
As a board-certified sleep physician, I have witnessed firsthand the transformative impact of artificial intelligence (AI) and machine learning (ML) in the field of sleep medicine. Their integration in both polysomnography (PSG) and home sleep testing (HST) has revolutionized the diagnosis and management of sleep disorders. In this article, we’ll […]
